Neurosense Therapeutics Ltd. (NRSN) at a glance

Neurosense Therapeutics Ltd. (NRSN) is a micro-cap Healthcare company. It trades at $0.76, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Value (50/100) and its weakest is Momentum (18/100). It carries above-market volatility, so expect larger swings.

Price

$0.76

Market cap

$26.5M

P/E ratio

n/a

Dividend yield

None

Beta

1.54

52-week range

$0.63 to $2.28